Breaking News Instant updates and real-time market news.

MU

Micron

$59.37

4.78 (8.76%)

, AVGO

Broadcom

$262.84

9.06 (3.57%)

11:06
03/13/18
03/13
11:06
03/13/18
11:06

Broadcom could look at Micron next with Qualcomm blocked, says KeyBanc

President Trump's order to block Broadcom's (AVGO) proposed takeover of Qualcomm (QCOM) also likely blocks the possibility of the company trying to acquire any other player with any military/defense exposure, such as Xilinx (XLNX), KeyBanc analyst John Vinh tells investors. However, he expects Broadcom to remain acquisitive and thinks Micron (MU) could be another potential target, citing a lack of security concerns and Broadcom's previous attempts to bid for Toshiba (TOSBF), he noted. Vinh reiterates his Overweight rating and $320 price target on Broadcom, adding that he sees the executive order as a "slight positive," since it removes a near-term distraction and overhang.

MU

Micron

$59.37

4.78 (8.76%)

AVGO

Broadcom

$262.84

9.06 (3.57%)

QCOM

Qualcomm

$62.81

-0.22 (-0.35%)

XLNX

Xilinx

$77.07

0.87 (1.14%)

TOSBF

Toshiba, also use TOSYY

$2.96

-0.04 (-1.33%)

TOSYY

Toshiba, also use TOSBF

$17.77

-0.115 (-0.64%)

  • 15

    Mar

  • 22

    Mar

  • 22

    Mar

  • 23

    Mar

  • 26

    Mar

  • 27

    Mar

  • 28

    Mar

  • 29

    Mar

  • 21

    May

  • 30

    May

MU Micron
$59.37

4.78 (8.76%)

03/12/18
EVER
03/12/18
NO CHANGE
Target $80
EVER
Outperform
Micron price target raised to $80 from $60 at Evercore ISI
Evercore ISI analyst C.J. Muse raised his price target on Micron to $80 from $60, stating that he thinks the memory market is "absolutely" different now with the DRAM industry consolidated to three players, all of whom are acting rational, and memory has become increasingly critical while the rising complexity has limited the magnitude of new supply. His sense is that Micron will move forward with capital returns "regardless of what we hear from the rating agencies" and predicts the company's analyst day on May 21 should bring more news about planned capital returns starting in FY19. Muse, who thinks Micron can earn $13 or more in EPS in calendar 2019, keeps an Outperform rating on Micron shares.
03/12/18
NOMU
03/12/18
NO CHANGE
Target $100
NOMU
Buy
Micron price target raised to $100 from $55 at Nomura Instinet
Nomura Instinet analyst Romit Shah raised his price target for Micron Technology to $100 ahead of what he believes to be a "major breakout" for the shares. Micron closed Friday down 63c to $54.59. After consolidating over the last four months, the shares are in the "early stages of another major breakout," Shah tells investors in a research note. The analyst upped his estimates for Micron and keeps a Buy rating on the name.
03/08/18
MSCO
03/08/18
NO CHANGE
MSCO
Micron, Seagate among best positioned to benefit from cloud spending, says Morgan Stanley
Morgan Stanley analyst Katy Huberty said the firm's cloud CapEx tracker indicates 4 points of growth acceleration in 2018, which she noted is up from a 6 point deceleration in the previous reading. Morgan Stanley analyst forecasts imply average 2018 CapEx growth of 28%, up from 23% and 24% in 2016 and 2017, respectively, noted Huberty. She sees Arista (ANET), Micron (MU) and Seagate (STX) as among the most positively exposed to greater investment in hyperscale data centers.
03/08/18
KEYB
03/08/18
NO CHANGE
Target $65
KEYB
Overweight
Micron price target raised to $65 from $53 at KeyBanc
KeyBanc analyst Weston Twigg raised his price target for Micron Technology to $65 and keeps an Overweight rating on the shares. Micron closed yesterday up 23c to $53.97. Sequential average selling price declines will be less severe than previously modeled over the next few quarters, Twigg tells investors in a research note. He believes the memory markets "remain very healthy" and sees good mid- to long-term trends for the company. NAND pricing risk appears less severe than expected while DRAM pricing remains strong, Twigg contends. He raised his fiscal 2018 earnings per share estimate for Micron to $10.66 from $10.26 and fiscal 2019 estimate to $10.12 from $9.82.
AVGO Broadcom
$262.84

9.06 (3.57%)

03/13/18
BNCH
03/13/18
NO CHANGE
BNCH
Buy
Marvell-Cavium deal in focus after denial of Broadcom-Qualcomm, says Benchmark
After President Trump signed an order prohibiting Broadcom's (AVGO) attempt to take over Qualcomm (QCOM), Benchmark analyst Gary Mobley said the news may cause investors to question CFIUS approval for the planned tie-up of Marvell (MRVL) with Cavium (CAVM). It is possible Marvell may have to re-domicile in the U.S. from Bermuda, which may delay the merger by a few months and would increase Marvell's tax rate unfavorably, he said. Mobley, who think it is hard to say whether the President will shoot down the deal, noted that CFIUS and China's MOFCOM are the last two regulatory hurdles for Marvell and Cavium's deal. He has a Buy rating on Marvell shares.
03/13/18
ADAM
03/13/18
NO CHANGE
Target $86
ADAM
Buy
Qualcomm weakness a buying opportunity, says Canaccord
Canaccord analyst T. Michael Walkley noted the White House blocked the takeover of Qualcomm (QCOM) by Broadcom (AVGO) in the interest of national security. He expects the shares of Qualcomm to be weak as a result and recommends investors buy the shares on the pullback. He left his estimates and price target the same and believes its valuation will be compelling, especially if it closes the NXP Semiconductor (NXPI) deal. Walkley reiterated his Buy rating and $86 price target on Qualcomm shares.
03/13/18
RHCO
03/13/18
NO CHANGE
Target $335
RHCO
Broadcom price target lowered to $335 from $344 at SunTrust
SunTrust analyst William Stein lowered his price target on Broadcom (AVGO) to $335 after the company's bid for Qualcomm (QCOM) came undone. Stein says the new price target is based on Broadcom's stand-alone valuation and potential accretion from another medium-sized deal, forecasting the company to pursue another target "in due time". The analyst keeps his Buy rating on Broadcom, adding that M&A has been a "massive driver" of its earnings growth.
QCOM Qualcomm
$62.81

-0.22 (-0.35%)

03/12/18
BMOC
03/12/18
NO CHANGE
Target $345
BMOC
Outperform
Broadcom price target raised to $345 from $330 at BMO Capital
BMO Capital analyst Ambrish Srivastava raised his price target on Broadcom (AVGO) to $345 citing his new FY18 EPS target of $5.10 based on the company's revised guidance in January. Srivastava keeps his Outperform rating going into the next earnings update, noting that fundamentals for Broadcom remain "strong" even as much of the investor focus is around its bid for Qualcomm (QCOM). The analyst forecasts Broadcom Wireless Communications segment to grow 10% on the quarter and Enterprise Storage segment to grow 40% on the quarter.
XLNX Xilinx
$77.07

0.87 (1.14%)

02/22/18
RBCM
02/22/18
NO CHANGE
Target $325
RBCM
Top Pick
RBC finds takeover targets for Broadcom should Qualcomm deal fail
RBC Capital analyst Amit Daryanani finds it prudent to think about other takeover options for Broadcom (AVGO) should its attempt to acquire Qualcomm (QCOM) fail. Broadcom is in a "unique position" as it generates $9B-$10B of free cash flow annually, has balance sheet that is "almost net debt neutral" and a management team "that has impeccable history in integrating assets," Daryanani tells investors in a research note titled "If not QCOM, Who Is Next?" The analyst sees potential targets in Xilinx (XLNX), Analog Devices (ADI), Maxim Integrated (MXIM), Marvell Technology (MRVL) and Microsemi (MSCC). Daryanani keeps a Top Pick rating on Broadcom with a $325 price target. He believes the company has the ability to sustain double-digit growth with or without Qualcomm.
01/23/18
KEYB
01/23/18
NO CHANGE
Target $87
KEYB
Overweight
Xilinx price target raised to $87 from $78 at KeyBanc
KeyBanc analyst John Vinh raised his price target for Xilinx (XLNX) to $87 from $78 ahead of Q3 earnings. The analyst views Microsoft's (MSFT) AI hardware strategy of using FPGAs, particularly in its latest ML DNN platform, as validation of why he believes Xilinx will ultimately succeed as a cloud silicon enabler versus CPUs/GPUs in the cloud. He reiterates an Overweight rating on Xilinx shares.
01/25/18
FBCO
01/25/18
NO CHANGE
Target $85
FBCO
Outperform
Xilinx price target raised to $85 from $75 at Credit Suisse
Credit Suisse analyst John Pitzer raised his price target for Xilinx to $85 from $75 following better than expected quarterly results. The analyst reiterates an Outperform rating on the shares.
01/25/18
RHCO
01/25/18
NO CHANGE
Target $79
RHCO
Hold
Xilinx price target raised to $79 from $69 at SunTrust
SunTrust analyst William Stein raised his price target on Xilinx to $79 and kept his Hold rating after Q3 earnings. Stein notes that while revenues excluding Comms and Data Center sales continued to outperform amid 20% annual growth in automotive and the emerging exposure to cryptocurrencies, Comms and Data end market underperformed again and may remain challenging until 5G fully launches around 2020.
TOSBF Toshiba, also use TOSYY
$2.96

-0.04 (-1.33%)

12/13/17
DBAB
12/13/17
UPGRADE
DBAB
Buy
Toshiba upgraded to Buy from Hold at Deutsche Bank
01/05/18
FBCO
01/05/18
NO CHANGE
Target $42
FBCO
Outperform
Brookfield Business Partners price target raised to $42 from $34 at Credit Suisse
Credit Suisse analyst Nick Stogdill noted that Brookfield Business Partners (BBU) and its institutional partners will acquire 100% of Westinghouse Electric from Toshiba (TOSBF) for $4.6B, which he views as positive news from both a strategic and financial perspective. The analyst, who increased his 2018 EPS estimate 11% to $3.15 to reflect the deal, keeps an Outperform rating on Brookfield Business Partners and raised his price target on the stock to $42.
01/09/18
RBCM
01/09/18
NO CHANGE
Target $48
RBCM
Sector Perform
Seagate price target raised to $48 from $43 at RBC Capital
RBC Capital analyst Amit Daryanani raised his price target on Seagate (STX) to $48 after the company's positive December-quarter pre-announcement and its long-term NAND supply agreement with Toshiba (TOSBF). Daryanani says the discussion around EB shipments and capacity-per-drive metrics suggests that the company is gaining share in the 10TB market. The analyst keeps his Sector Perform rating on Seagate, noting he is "cognizant" of the company's near-term tailwinds.
02/20/18
RBCM
02/20/18
NO CHANGE
Target $115
RBCM
Outperform
Western Digital may be an LBO candidate, says RBC Capital
RBC Capital analyst Amit Daryanani contends that Western Digital (WDC) could be an attractive LBO candidate, considering that the stock has languished at an "attractive valuation" since the Toshiba (TOSBF) resolution on misplaced NAND cycle concerns. The analyst also notes that the likelihood of an LBO is high because of several private equity firms' involvement in the Toshiba asset sale. Daryanani keeps his Outperform rating with a $115 price target, adding that a "sizable potential EPS upside and room for multiple expansion remain" for the stock.
TOSYY Toshiba, also use TOSBF
$17.77

-0.115 (-0.64%)

12/13/17
COWN
12/13/17
NO CHANGE
COWN
Outperform
JV settlement positive for both Western Digital and Seagate, says Cowen
Cowen analyst Karl Ackerman said Western Digital's (WDC) settlement agreement with Toshiba (TOSBF) is largely in line with his prior expectations and should lead to a better multiple for Western Digital shares since it removes one of investors' primary fears. The deal is also a positive for Seagate (STX), according to Ackerman, as it gives that company an opportunity to access NAND supply from Toshiba. The analyst, who maintains an Outperform rating on Western Digital, added that the company's updated guidance proves his prior view that Street estimates were "way too low."

TODAY'S FREE FLY STORIES

03:05
12/17/18
12/17
03:05
12/17/18
03:05
General news
FX Update: Narrow ranges have prevailed »

FX Update: Narrow ranges…

FII

Federated Investors

$24.65

-0.02 (-0.08%)

21:40
12/16/18
12/16
21:40
12/16/18
21:40
Initiation
Federated Investors initiated at Gabelli »

Federated Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIII

G-III Apparel

$28.68

-0.29 (-1.00%)

21:37
12/16/18
12/16
21:37
12/16/18
21:37
Upgrade
G-III Apparel rating change at Stifel »

G-III Apparel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLXT

Calyxt

$9.88

0.4 (4.22%)

21:34
12/16/18
12/16
21:34
12/16/18
21:34
Upgrade
Calyxt rating change at Goldman Sachs »

Goldman upgrades Calyxt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLXT

Calyxt

$9.88

0.4 (4.22%)

20:23
12/16/18
12/16
20:23
12/16/18
20:23
Upgrade
Calyxt rating change at Goldman Sachs »

Calyxt upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEQP

Crestwood Equity

$32.29

0.47 (1.48%)

, EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

20:08
12/16/18
12/16
20:08
12/16/18
20:08
Recommendations
Crestwood Equity, EQT Midstream Partners analyst commentary at Goldman Sachs »

Goldman upgrades…

CEQP

Crestwood Equity

$32.29

0.47 (1.48%)

EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITW

Illinois Tool Works

$131.02

-2.26 (-1.70%)

19:57
12/16/18
12/16
19:57
12/16/18
19:57
Downgrade
Illinois Tool Works rating change at Deutsche Bank »

Illinois Tool Works…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWK

Stanley Black & Decker

$118.36

0.46 (0.39%)

19:57
12/16/18
12/16
19:57
12/16/18
19:57
Upgrade
Stanley Black & Decker rating change at Deutsche Bank »

Stanley Black &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$66.24

-1.04 (-1.55%)

, AET

Aetna

$0.00

(0.00%)

19:31
12/16/18
12/16
19:31
12/16/18
19:31
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

INCY

Incyte

$66.24

-1.04 (-1.55%)

AET

Aetna

$0.00

(0.00%)

ANTM

Anthem

$275.59

-4.93 (-1.76%)

CNC

Centene

$127.55

-5.3 (-3.99%)

CI

Cigna

$205.34

-6.63 (-3.13%)

HNT

Health Net

$0.00

(0.00%)

HUM

Humana

$300.41

-12.09 (-3.87%)

MOH

Molina Healthcare

$131.72

-11.19 (-7.83%)

UNH

UnitedHealth

$265.06

-7.2 (-2.64%)

WCG

WellCare

$236.90

-7.44 (-3.04%)

SNE

Sony

$51.32

-0.88 (-1.69%)

GOOG

Alphabet

$1,041.68

-21.44 (-2.02%)

GOOGL

Alphabet Class A

$1,050.62

-23.36 (-2.18%)

AAPL

Apple

$165.48

-5.45 (-3.19%)

BAC

Bank of America

$24.49

0.1 (0.41%)

BLK

BlackRock

$382.25

-5.29 (-1.37%)

CAT

Caterpillar

$126.78

0.79 (0.63%)

CVX

Chevron

$113.84

-2.15 (-1.85%)

DDAIF

Daimler AG

$0.00

(0.00%)

DAL

Delta Air Lines

$53.50

-0.03 (-0.06%)

ET

Energy Transfer LP

$14.08

-0.5 (-3.43%)

TOL

Toll Brothers

$32.23

-0.4 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 10

    Jan

  • 29

    Jan

  • 05

    Feb

  • 12

    Feb

  • 19

    Feb

  • 24

    Feb

  • 03

    Mar

EQT

EQT Corporation

$19.40

-0.78 (-3.87%)

18:54
12/16/18
12/16
18:54
12/16/18
18:54
Periodicals
EQT's board to seek meeting with Rice brothers, Reuters reports »

EQT Corporation's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

, EQGP

EQGP Holdings

$19.94

0.02 (0.10%)

18:31
12/16/18
12/16
18:31
12/16/18
18:31
Downgrade
EQT Midstream Partners, EQGP Holdings rating change at Goldman Sachs »

EQT Midstream downgraded…

EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

EQGP

EQGP Holdings

$19.94

0.02 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEQP

Crestwood Equity

$32.29

0.47 (1.48%)

18:28
12/16/18
12/16
18:28
12/16/18
18:28
Upgrade
Crestwood Equity rating change at Goldman Sachs »

Crestwood Equity upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$66.24

-1.04 (-1.55%)

17:52
12/16/18
12/16
17:52
12/16/18
17:52
Hot Stocks
Innovent, Incyte announce agreement for three clinical-stage candidates in China »

Incyte and Innovent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

NSANY

Nissan

$0.00

(0.00%)

, RNLSY

Renault

$0.00

(0.00%)

17:14
12/16/18
12/16
17:14
12/16/18
17:14
Periodicals
Renault seeking Nissan shareholder meeting amid Ghosn crisis, Reuters says »

Renault (RNLSY) requested…

NSANY

Nissan

$0.00

(0.00%)

RNLSY

Renault

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

T

AT&T

$30.24

0.33 (1.10%)

, CMCSA

Comcast

$36.32

-0.43 (-1.17%)

16:48
12/16/18
12/16
16:48
12/16/18
16:48
Hot Stocks
Box Office Battle: 'Spider-Verse' wins weekend with $35M »

Sony's (SNE)…

T

AT&T

$30.24

0.33 (1.10%)

CMCSA

Comcast

$36.32

-0.43 (-1.17%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$51.32

-0.88 (-1.69%)

FOX

21st Century Fox

$48.79

-0.09 (-0.18%)

FOXA

21st Century Fox

$49.06

-0.07 (-0.14%)

LGF.A

Lionsgate

$15.59

-0.16 (-1.02%)

DIS

Disney

$112.21

-1.17 (-1.03%)

VIAB

Viacom

$28.56

-0.31 (-1.07%)

VIA

Viacom

$31.23

-0.4 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 30

    Jan

  • 20

    Mar

ELGX

Endologix

$0.71

0.0232 (3.39%)

16:17
12/16/18
12/16
16:17
12/16/18
16:17
Conference/Events
Endologix to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRPO

Precipio

$0.19

-0.0111 (-5.63%)

16:11
12/16/18
12/16
16:11
12/16/18
16:11
Conference/Events
Precipio to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSB

Mesabi Trust

$25.15

-1.1 (-4.19%)

16:08
12/16/18
12/16
16:08
12/16/18
16:08
Conference/Events
Mesabi Trust to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNT

Melinta Therapeutics

$1.19

-0.1 (-7.75%)

16:02
12/16/18
12/16
16:02
12/16/18
16:02
Conference/Events
Melinta Therapeutics to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$75.63

-1.32 (-1.72%)

15:55
12/16/18
12/16
15:55
12/16/18
15:55
Periodicals
Exxon Mobil shareholders call for greenhouse gas reduction targets, Reuters says »

A number of institutional…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANTM

Anthem

$275.59

-4.93 (-1.76%)

, CNC

Centene

$127.55

-5.3 (-3.99%)

13:16
12/16/18
12/16
13:16
12/16/18
13:16
Periodicals
Health stocks preparing for market jolt after Obamacare ruling, Bloomberg says »

U.S. health-care stocks…

ANTM

Anthem

$275.59

-4.93 (-1.76%)

CNC

Centene

$127.55

-5.3 (-3.99%)

CI

Cigna

$205.34

-6.63 (-3.13%)

UNH

UnitedHealth

$265.06

-7.2 (-2.64%)

HUM

Humana

$300.41

-12.09 (-3.87%)

WCG

WellCare

$236.90

-7.44 (-3.04%)

MOH

Molina Healthcare

$131.72

-11.19 (-7.83%)

HNT

Health Net

$0.00

(0.00%)

AET

Aetna

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 05

    Feb

  • 19

    Feb

JELD

Jeld-Wen

$14.27

-0.46 (-3.12%)

13:02
12/16/18
12/16
13:02
12/16/18
13:02
Hot Stocks
Jeld-Wen announces final ruling in Steves & Sons litigation, to appeal decision »

Jeld-Wen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRA

Atara Biotherapeutics

$41.78

-0.74 (-1.74%)

12:55
12/16/18
12/16
12:55
12/16/18
12:55
Hot Stocks
Atara Biotherapeutics presents positive efficacy, safety results for EBV + LMS »

Atara Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$133.95

2.595 (1.98%)

12:41
12/16/18
12/16
12:41
12/16/18
12:41
Hot Stocks
BeiGene announces updated Phase 1A/1B data on tislelizumab »

BeiGene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

Jeld-Wen

$14.27

-0.46 (-3.12%)

12:35
12/16/18
12/16
12:35
12/16/18
12:35
Hot Stocks
Jeld-Wen ordered to divest Pennsylvania plant to restore competition »

Federal Judge Robert…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.